290 related articles for article (PubMed ID: 11935462)
1. Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus.
McCright IJ; Tsunoda I; Libbey JE; Fujinami RS
J Neurovirol; 2002 Apr; 8(2):100-10. PubMed ID: 11935462
[TBL] [Abstract][Full Text] [Related]
2. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
[TBL] [Abstract][Full Text] [Related]
3. The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.
Senkowski A; Shim B; Roos RP
J Neurovirol; 1995 Mar; 1(1):101-10. PubMed ID: 9222346
[TBL] [Abstract][Full Text] [Related]
4. Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis.
McCright IJ; Tsunoda I; Whitby FG; Fujinami RS
J Virol; 1999 Apr; 73(4):2814-24. PubMed ID: 10074129
[TBL] [Abstract][Full Text] [Related]
5. The generation and characterisation of neutralising antibodies against the Theiler's murine encephalomyelitis virus (TMEV) GDVII capsid reveals the potential binding site of the host cell co-receptor, heparan sulfate.
Upfold N; Ross C; Bishop ÖT; Luke GA; Knox C
Virus Res; 2018 Jan; 244():153-163. PubMed ID: 29155139
[TBL] [Abstract][Full Text] [Related]
6. Antigens to viral capsid and non-capsid proteins are present in brain tissues and antibodies in sera of Theiler's virus-infected mice.
Cameron K; Zhang X; Seal B; Rodriguez M; Njenga MK
J Virol Methods; 2001 Jan; 91(1):11-9. PubMed ID: 11164481
[TBL] [Abstract][Full Text] [Related]
7. A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype.
Sato S; Zhang L; Kim J; Jakob J; Grant RA; Wollmann R; Roos RP
Virology; 1996 Dec; 226(2):327-37. PubMed ID: 8955052
[TBL] [Abstract][Full Text] [Related]
8. Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus.
Libbey JE; McCright IJ; Tsunoda I; Wada Y; Fujinami RS
J Neurovirol; 2001 Apr; 7(2):97-104. PubMed ID: 11517382
[TBL] [Abstract][Full Text] [Related]
9. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination.
Zheng L; Calenoff MA; Dal Canto MC
J Neuroimmunol; 2001 Aug; 118(2):256-67. PubMed ID: 11498260
[TBL] [Abstract][Full Text] [Related]
10. Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.
Tsunoda I; Wada Y; Libbey JE; Cannon TS; Whitby FG; Fujinami RS
J Virol; 2001 Aug; 75(16):7494-505. PubMed ID: 11462022
[TBL] [Abstract][Full Text] [Related]
11. Theiler's virus strain-dependent induction of innate immune responses in RAW264.7 macrophages and its influence on viral clearance versus viral persistence.
Steurbaut S; Rombaut B; Vrijsen R
J Neurovirol; 2007; 13(1):47-55. PubMed ID: 17454448
[TBL] [Abstract][Full Text] [Related]
12. Mutation of predicted virion pit residues alters binding of Theiler's murine encephalomyelitis virus to BHK-21 cells.
Hertzler S; Luo M; Lipton HL
J Virol; 2000 Feb; 74(4):1994-2004. PubMed ID: 10644372
[TBL] [Abstract][Full Text] [Related]
13. Theiler's murine encephalomyelitis virus (TMEV): the role of a small out-of-frame protein in viral persistence and demyelination.
Obuchi M; Ohara Y
Jpn J Infect Dis; 1999 Dec; 52(6):228-33. PubMed ID: 10738359
[TBL] [Abstract][Full Text] [Related]
14. Subcellular localisation of Theiler's murine encephalomyelitis virus (TMEV) capsid subunit VP1 vis-á-vis host protein Hsp90.
Ross C; Upfold N; Luke GA; Bishop ÖT; Knox C
Virus Res; 2016 Aug; 222():53-63. PubMed ID: 27269472
[TBL] [Abstract][Full Text] [Related]
15. Theiler's murine encephalomyelitis virus infection induces early expression of c-fos in astrocytes.
Rubio N; Martin-Clemente B
Virology; 1999 May; 258(1):21-9. PubMed ID: 10329564
[TBL] [Abstract][Full Text] [Related]
16. Replacement of loop II of VP1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence, and demyelination.
Wada Y; McCright IJ; Whitby FG; Tsunoda I; Fujinami RS
J Virol; 1998 Sep; 72(9):7557-62. PubMed ID: 9696853
[TBL] [Abstract][Full Text] [Related]
17. Persistent infection of RAW264.7 macrophages with the DA strain of Theiler's murine encephalomyelitis virus: An in vitro model to study viral persistence.
Steurbaut S; Rombaut B; Vrijsen R
J Neurovirol; 2006 Apr; 12(2):108-15. PubMed ID: 16798672
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.
Jnaoui K; Michiels T
Virology; 1998 May; 244(2):397-404. PubMed ID: 9601508
[TBL] [Abstract][Full Text] [Related]
19. Role of sialyloligosaccharide binding in Theiler's virus persistence.
Zhou L; Lin X; Green TJ; Lipton HL; Luo M
J Virol; 1997 Dec; 71(12):9701-12. PubMed ID: 9371636
[TBL] [Abstract][Full Text] [Related]
20. Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding.
Tsunoda I; Libbey JE; Fujinami RS
J Neurovirol; 2009 Jan; 15(1):81-9. PubMed ID: 19115131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
